Related references
Note: Only part of the references are listed.Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costs
Giuseppe Milone et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts
Sergio Rutella et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Addition of plerixafor for CD34+cell mobilization in six healthy stem cell donors ensured satisfactory grafts for transplantation
Anne Werner Hauge et al.
TRANSFUSION (2014)
Differences in the Phenotype, Cytokine Gene Expression Profiles, and In Vivo Alloreactivity of T Cells Mobilized with Plerixafor Compared with G-CSF
Andreas Lundqvist et al.
JOURNAL OF IMMUNOLOGY (2013)
Plerixafor 'just in time' for stem cell mobilization in a normal donor
J. Schriber et al.
BONE MARROW TRANSPLANTATION (2011)
Successful mobilization of PBSCs in a healthy volunteer donor by addition of plerixafor after failure of mobilization with G-CSF alone
T. Neumann et al.
BONE MARROW TRANSPLANTATION (2011)
A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers
Steven J. Lemery et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Factors Associated with Peripheral Blood Stem Cell Yield in Volunteer Donors Mobilized with Granulocyte Colony-Stimulating Factors: The Impact of Donor Characteristics and Procedural Settings
Tso-Fu Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used
Stuart J. Ings et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Mobilisation with G-CSF in healthy donors promotes a high but temporal deregulation of genes
JM Hernández et al.
LEUKEMIA (2005)
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
HE Broxmeyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Splenic rupture after granulocyte-colony-stimulating factor mobilization in a peripheral blood progenitor cell donor
H Balaguer et al.
TRANSFUSION (2004)
Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells
A Nagler et al.
EXPERIMENTAL HEMATOLOGY (2004)
Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization
AP Dincer et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
WC Liles et al.
BLOOD (2003)
G-CSF-induced spleen size changes in peripheral blood progenitor cell donors
D Stroncek et al.
TRANSFUSION (2003)
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases
P Anderlini et al.
BONE MARROW TRANSPLANTATION (2001)
Share Paper
